Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zannetti

Showing results (211-220 of 264) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2007
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancerJ-C Eymard, F Priou, A Zannetti, et al.
Experimental Cell Research|September 27, 2014
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironmentEnrica Borsi, Giulia Perrone, Carolina Terragna, et al.
Oncology|January 22, 2010
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumorsLuigi Insabato, Ivano Amelio, Maria Quarto, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2014
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myelomaElena Zamagni, Cristina Nanni, Paola Tacchetti, et al.
Journal of Virology|September 27, 2013
The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expressionNaveed Shahzad, Masahiro Shuda, Tarik Gheit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2014
TLR9 transcriptional regulation in response to double-stranded DNA virusesClaudia Zannetti, Peggy Parroche, Marine Panaye, et al.
Dermatologic Therapy|August 24, 2012
VAC therapy for wound management in patients with contraindications to surgical treatmentLuca Negosanti, Rossella Sgarzani, Parissa Nejad, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancerSimona Camorani, Margherita Passariello, Lisa Agnello, et al.
Biopolymers|March 27, 2003
Radiolabeling approaches for cholecystokinin B receptor imagingL Aloj, M R Panico, C Caracó, et al.
Transplantation and Cellular Therapy|March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective StudyBeatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Pageof 27

Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2007
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancerJ-C Eymard, F Priou, A Zannetti, et al.
Experimental Cell Research|September 27, 2014
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironmentEnrica Borsi, Giulia Perrone, Carolina Terragna, et al.
Oncology|January 22, 2010
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumorsLuigi Insabato, Ivano Amelio, Maria Quarto, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2014
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myelomaElena Zamagni, Cristina Nanni, Paola Tacchetti, et al.
Journal of Virology|September 27, 2013
The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expressionNaveed Shahzad, Masahiro Shuda, Tarik Gheit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2014
TLR9 transcriptional regulation in response to double-stranded DNA virusesClaudia Zannetti, Peggy Parroche, Marine Panaye, et al.
Dermatologic Therapy|August 24, 2012
VAC therapy for wound management in patients with contraindications to surgical treatmentLuca Negosanti, Rossella Sgarzani, Parissa Nejad, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2020
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancerSimona Camorani, Margherita Passariello, Lisa Agnello, et al.
Biopolymers|March 27, 2003
Radiolabeling approaches for cholecystokinin B receptor imagingL Aloj, M R Panico, C Caracó, et al.
Transplantation and Cellular Therapy|March 30, 2021
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective StudyBeatrice Anna Zannetti, Francesco Saraceni, Claudia Cellini, et al.
Pageof 27